This article has been updated from a previous version to include comments from Quidel's Q3 earnings call.

NEW YORK (GenomeWeb News) — Quidel reported after the close of the market on Wednesday that its third quarter revenues inched up nearly 2 percent year over year as sales of flu products increased but were offset by flagging sales of Strep A and pregnancy lateral flow tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.